Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chatenoud

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
Transplantation|March 27, 1995
The effects of donor and recipient endotoxemia on TNF alpha production and mortality in the rat model of syngenic orthotopic liver transplantationD Azoulay, I Astarcioglu, A Lemoine, et al.
Gynecologic and Obstetric Investigation|January 1, 1997
Semen parameters and conception rates after intraperitoneal inseminationG Ragni, F Parazzini, F Sapienza, et al.
Contributions to Nephrology|January 1, 1987
Interleukin-2 production and targeting in hemodialyzed patientsL Chatenoud, B Dugas, G Beaurain, et al.
The American Journal of Psychiatry|May 1, 1989
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 productionF Villemain, L Chatenoud, A Galinowski, et al.
Transplantation|October 3, 1999
CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysisA Herbelin, D Abramowicz, D de Groote, et al.
International Journal of Epidemiology|June 28, 2000
Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei DiabeticiD Fedele, A Bortolotti, C Coscelli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 23, 2016
Control of asthma by omalizumab: the role of CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T cellsF Amat, P Tallon, A P Foray, et al.
The Journal of Pediatrics|December 1, 1987
Effects of cyclosporine in severe systemic lupus erythematosusG Feutren, S Querin, L H Noël, et al.
Transplantation|December 28, 1999
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejectionP J Friend, G Hale, L Chatenoud, et al.
Lancet (London, England)|December 6, 1980
Deficit of suppressor T cells in active multiple sclerosisM A Bach, F Phan-Dinh-Tuy, E Tournier, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
Transplantation|March 27, 1995
The effects of donor and recipient endotoxemia on TNF alpha production and mortality in the rat model of syngenic orthotopic liver transplantationD Azoulay, I Astarcioglu, A Lemoine, et al.
Gynecologic and Obstetric Investigation|January 1, 1997
Semen parameters and conception rates after intraperitoneal inseminationG Ragni, F Parazzini, F Sapienza, et al.
Contributions to Nephrology|January 1, 1987
Interleukin-2 production and targeting in hemodialyzed patientsL Chatenoud, B Dugas, G Beaurain, et al.
The American Journal of Psychiatry|May 1, 1989
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 productionF Villemain, L Chatenoud, A Galinowski, et al.
Transplantation|October 3, 1999
CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysisA Herbelin, D Abramowicz, D de Groote, et al.
International Journal of Epidemiology|June 28, 2000
Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei DiabeticiD Fedele, A Bortolotti, C Coscelli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 23, 2016
Control of asthma by omalizumab: the role of CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T cellsF Amat, P Tallon, A P Foray, et al.
The Journal of Pediatrics|December 1, 1987
Effects of cyclosporine in severe systemic lupus erythematosusG Feutren, S Querin, L H Noël, et al.
Transplantation|December 28, 1999
Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejectionP J Friend, G Hale, L Chatenoud, et al.
Lancet (London, England)|December 6, 1980
Deficit of suppressor T cells in active multiple sclerosisM A Bach, F Phan-Dinh-Tuy, E Tournier, et al.
Pageof 26